ExodusPoint Capital Management’s Agilon Health AGL Stock Holding History

ExodusPoint Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-466	Closed	-$27K	–	1480
2025 Q2	$27K	Buy	+466	New	+$37.4K	﹤0.01%	1380
2024 Q4	–	Sell	-12,224	Closed	-$1.2M	–	1461
2024 Q3	$1.2M	Buy	+12,224	New	+$1.58M	0.01%	921
2023 Q4	–	Sell	-1,043	Closed	-$463K	–	1414
2023 Q3	$463K	Sell	1,043 -3,407	-77%	-$1.54M	﹤0.01%	1269
2023 Q2	$1.93M	Buy	+4,450	New	+$2.5M	0.02%	817
2022 Q4	–	Sell	-1,857	Closed	-$1.09M	–	1594
2022 Q3	$1.09M	Buy	+1,857	New	+$1.11M	0.01%	1075
2022 Q2	–	Sell	-3,465	Closed	-$2.2M	–	1894
2022 Q1	$2.2M	Buy	+3,465	New	+$1.79M	0.03%	729
2021 Q3	–	Sell	-705	Closed	-$715K	–	2048
2021 Q2	$715K	Buy	+705	New	+$618K	0.01%	1175

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ExodusPoint Capital Management's AGL Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 466 shares — an estimated $27K sold.

ExodusPoint Capital Management first reported a position in AGL in Q2 2021 and held it in 7 quarters. The position peaked at $2.2M in Q1 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

ExodusPoint Capital Management reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 466 Agilon Health shares in Q3 2025, an estimated $27K.
ExodusPoint Capital Management first reported a position in Agilon Health in Q2 2021 and held it in 7 quarters.
ExodusPoint Capital Management's Agilon Health position peaked at $2.2M in Q1 2022.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.